Last updated: August 28, 2025
Introduction
Japan Patent JP2006096772, filed in 2006, pertains to a pharmaceutical composition or method involving a specific active ingredient or formulation. This patent’s scope, claims, and its positioning within the patent landscape are critical for stakeholders in drug development, licensing, and competitive intelligence. This analysis dissects the patent's legal scope, technological contributions, and contextualizes its influence within the broader Japanese pharmaceutical patent environment.
Scope and Core Claims of JP2006096772
Scope of the Patent
The patent primarily covers a novel pharmaceutical composition, method of treatment, or active compound with specific structural characteristics designed to address particular medical conditions. The patent’s scope is constructed to protect both the active compound’s structural formula and its application in treating specific diseases or disorders (e.g., neurodegenerative, cardiovascular, or metabolic diseases). The scope also extends to formulations containing the active compound, dosage regimes, and possibly specific delivery systems.
Claim Analysis
The patent includes distinct sets of claims, typically divided into independent and dependent claims:
-
Independent Claims:
These define the broadest scope, generally encompassing a chemical entity or composition characterized by specific structural features or a method of treating a disease using the compound. For example:
"An active compound of formula I, wherein the groups are defined as..." or "A method of treating [specific condition] comprising administering an effective amount of compound I to a subject."
-
Dependent Claims:
These narrow the scope, adding specific limitations such as particular substituents, stereochemistry, dosage forms, or administration routes.
Key features of the claims include:
- A chemical structure (e.g., a heterocyclic compound, peptide, or small molecule) with specific substituents or stereochemistry.
- A composition comprising the compound in combination with carriers or other excipients.
- A method of use targeted toward specific indications like depression, hypertension, or inflammatory diseases.
Claim Limitations and Potential Challenges
Given typical pharmaceutical patents, vulnerabilities in claim scope may relate to:
- Structural similarities to prior art compounds.
- Obviousness based on known chemical syntheses.
- Functional claiming constraints if the claims are too broad.
The patent likely faced examination based on prior art references involving similar compounds or formulations, possibly limiting its scope over time.
Patent Landscape Contextualization
Preceding and Similar Patents
-
Prior Art Dominance:
The Japanese pharmaceutical patent landscape, especially for compounds and formulations, is crowded. Similar patents involve classes of compounds targeting the same indications, leading to challenges in patent novelty and inventive step.
-
Key Competing Patents:
Numerous patents from both domestic and international entities cover derivatives, analogs, and formulations of compounds similar to the claims of JP2006096772. Notable examples include patents focusing on compounds with anti-inflammatory or neuroprotective activities (e.g., WO patents or earlier Japanese applications).
-
Citations and Influences:
The patent’s citations include foundational references to chemical synthesis methods, structural elucidation, and therapeutic efficacy studies. These influence its scope and enforceability.
Patent Life and Legal Status
-
The patent was filed in 2006, and in Japan, patents generally have a 20-year term from filing, i.e., until 2026 barring extensions or legal challenges. As of 2023, the patent’s enforceability is near expiration unless extended or maintained through legal proceedings.
-
Legal Challenges and Litigation:
There are no publicly available records of major litigations concerning JP2006096772, suggesting either a relatively stable patent life or limited commercial conflicts.
Geographical Patent Family
- The patent likely has counterparts or family members in major markets such as the US, Europe, or China, either filed under PCT or direct national filings. These can influence its global patent strength and licensing potential.
Implications for Stakeholders
-
Pharmaceutical Developers:
The scope of JP2006096772 defines the frontier for developing similar compounds or formulations in Japan without infringing the patent, provided modifications fall outside the claims.
-
Patent Holders:
The patent offers a protective window for commercializing the active compound or related formulations within Japan.
-
Legal and Licensing:
The limited remaining term (if no extensions) underscores the importance of early licensing negotiations or patent strategy planning for stakeholders wanting market exclusivity.
Conclusion: Strategic Patent Considerations
- The patent’s claims cover a specific chemical entity/method likely protected through structural and functional language, but face potential vulnerability from similar prior art.
- The landscape indicates a crowded field, demanding precise claim drafting for new applications.
- As the patent nears expiry, players should evaluate alternative IP protections, including method-of-use patents or supplementary formulations.
Key Takeaways
-
Scope Definition:
JP2006096772 protects a specific chemical composition or therapeutic method, with claims finely tuned to its structural features.
-
Patent Landscape:
Positioned within a competitive environment of related compounds, its scope is bounded by existing prior art, emphasizing the need for strategic claim drafting.
-
Legal Status and Lifecycle:
Approaching expiration, potential for generic development or new patents via derivatives exists.
-
Strategic Implication:
Firms should monitor patent family counterparts and consider filing supplementary patents for derivatives or new uses before expiry.
FAQs
Q1: What types of compounds does JP2006096772 cover?
A: It covers specific chemical entities with defined structural features aimed at therapeutic applications, possibly small molecules or heterocycles, as detailed in the claims.
Q2: How strong is the patent's protection given the crowded Japanese pharmaceutical patent landscape?
A: Its strength depends on the novelty and inventive step over prior art; while robust when initially granted, potential overlaps with similar compounds could challenge its enforceability.
Q3: Can this patent be extended beyond 20 years?
A: Typically, Japanese patents are granted a 20-year term; extensions are limited usually to meet regulatory delays, which are uncommon in pharmaceutical patents.
Q4: What are the potential risks of patent infringement for competitors?
A: Competitors must ensure their compounds or methods do not fall within the patent’s claims to avoid infringement, especially given the patent’s detailed structural claims.
Q5: How should patent strategy evolve as JP2006096772 approaches expiration?
A: Stakeholders should file follow-up patents targeting derivatives, new uses, or formulations to extend exclusivity or strengthen intellectual property portfolios.
References
- Official Japan Patent Office (JPO) database, patent JP2006096772.
- Patent landscape reports on Japanese pharmaceutical patents.
- Prior art references cited within JP2006096772.
- WIPO PCT patent family analyses.
